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Background
Amyotrophic lateral sclerosis (ALS) is a late onset neuro-
degenerative disorder characterized by the loss of motor
neurons resulting in a progressive paralysis that ultimately
leads to death. Although the majority of cases are sporadic,
some cases are caused by genetic mutation in Superoxide
Dismutase 1 (SOD1) where mutations yield misfolded pro-
tein leading to an unknown toxic gain of function. Mito-
chondria have long been considered a target of mutant
SOD1 toxicity. Mitochondrial morphological abnormal-
ities are an early feature in the pathology of ALS in both
patients and animal models and various aspects of mito-
chondrial dysfunction have been reported in ALS models
although no consensus exists. How this primarily cytosolic
protein can affect mitochondria remains to be established.
Using antibodies specific for misfolded SOD1, we have
previously shown misfolded SOD1 to be associated with
the outer membrane of spinal cord mitochondria from
ALS animal models. We hypothesize that the mitochon-
drial association of misfolded SOD1 negatively impacts
key aspects of mitochondrial function.
Materials and methods
Using a novel flow cytometric assay, spinal cord mitochon-
dria isolated from rodent models overexpressing mutant
SOD1 were immunolabelled with an antibody targeted to
misfolded SOD1 (B8H10), and fluorescent indicator probes
were used to assess damage tracking with the presence of
the misfolded protein on the mitochondrial surface.
Results
Using two antibodies targeted to misfolded SOD1,
B8H10 and C4F6, we find selectivity for the B8H10-
reactive misfolded SOD1 for spinal cord mitochondria
isolated from SOD1G93A rats. In contrast, C4F6-reactive
SOD1 is not mitochondrially associated. Here, we report
an age-dependent deposition of B8H10-reactive SOD1
on spinal cord mitochondria in two different mutant
SOD1 models. The presence of misfolded SOD1 on the
mitochondrial surface appeared before other markers of
pathology including weight loss, gliosis and significant
loss of motor neurons. Mitochondria labelling positively
for B8H10-reactive SOD1 had increased mitochondrial
volume, produced excess superoxide, and had increased
exposure of the toxic BH3 domain of Bcl-2. Lastly,
B8H10-reactive misfolded SOD1 was found in lysates
and mitochondrial fractions of lymphoblasts derived
from ALS patients carrying SOD1 mutations, but not in
controls.
Conclusions
This assay identified dysfunction of a mitochondrial sub-
population coated with B8H10-reactive SOD1 which
appeared prior to classic markers of pathology, and thus
may be especially relevant to disease onset. That
B8H10-reactive misfolded was also present in patient
lymphoblasts as well as animal models demonstrates the
universal nature of this misfolded conformer. How mis-
folded evokes these damages to mitochondria is pre-
sently under evaluation.
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